Chart — Pharmacology
High-Alert Medication Chart
ISMP-based high-alert medication categories — primary risk, monitoring requirements, and nursing safety actions for the medications most likely to cause serious harm when administered in error.
Educational use only. High-alert medication protocols, double-check requirements, and approved formularies are facility-specific. Always follow your institution's policies for high-alert medications. This material supports nursing education and exam review. It is not medical advice and is not a substitute for clinical judgment, institutional policy, or medical direction. Always follow facility protocols and current provider orders.
High-Alert Medications — Safety Reference
| Medication Category | Primary Risk | Monitoring | Nursing Safety Actions |
|---|---|---|---|
| Insulin | Hypoglycemia (rapid and life-threatening); wrong type error | Blood glucose before each dose; hourly if IV infusion; K⁺ during IV insulin | Independent double-check for all doses; confirm meal delivery before prandial insulin; have glucose source available; write "units" (not "U") |
| Anticoagulants | Hemorrhage (fatal); HIT with heparin (paradoxical thrombosis) | aPTT (heparin), INR (warfarin), anti-Xa (LMWH if indicated), platelet count (heparin q2–3 days) | Independent double-check; verify lab values before administration; bleeding assessment at every interaction; know reversal agents |
| Opioids | Respiratory depression; sedation; apnea; death | Respiratory rate, SpO₂, sedation level (POSS or RASS), pain score before each dose | Double-check IV infusions; have naloxone immediately accessible; use lowest effective dose; continuous monitoring for IV PCA or infusion; assess sedation before dose |
| Vasopressors | Severe hypertension or hypotension; fatal dysrhythmia; tissue ischemia from extravasation | Continuous arterial line BP monitoring; cardiac monitoring; IV site assessment q1–2 hr for extravasation | Use smart pump with drug library; central line preferred; titrate slowly per protocol; document each dose change; know dose ranges |
| Concentrated Electrolytes | Cardiac arrest; fatal dysrhythmia (concentrated KCl); cerebral edema (hypertonic saline) | Cardiac monitoring during infusion; electrolyte levels; serum osmolality (hypertonic saline) | Concentrated KCl must not be stored on nursing units without pharmacy preparation; ICU monitoring for hypertonic saline; never infuse Ca²⁺ and phosphate simultaneously |
| Neuromuscular Blocking Agents | Complete respiratory paralysis — fatal without ventilatory support | Continuous ventilator monitoring; train-of-four monitoring; sedation level | Store separately with warning labels; only use with immediate airway capability; never given to awake, unsedated patients; Sugammadex reverses rocuronium/vecuronium |
| Sedatives / Hypnotics | Respiratory depression; hemodynamic instability; over-sedation | RASS or SAS sedation scale; respiratory rate, SpO₂; BP continuously for propofol | Propofol requires ICU-level monitoring; daily sedation vacation assessment; benzodiazepines increase delirium and fall risk in elderly |
| Antineoplastics / Chemotherapy | Severe immunosuppression; organ toxicity; death from incorrect route (vincristine intrathecal) | CBC, organ function per protocol; mucositis; extravasation site | Specialized training and PPE required; pharmacist verification mandatory; vincristine — intrathecal administration is sentinel event; double-check protocols before every dose |
Independent Double-Check Requirements
An independent double-check requires a second nurse to independently (without seeing the first nurse's calculation) verify the following before high-alert medication administration:
| Check Item |
|---|
| Patient identity (two identifiers) |
| Correct drug and drug form |
| Correct dose and concentration |
| Correct route of administration |
| Correct rate (for IV infusions) |
| Correct time |
| Relevant lab values (e.g., BG before insulin, aPTT before heparin) |
| Pump settings (for IV infusions) |
Common High-Alert Medication Errors
- Insulin — wrong type: Giving long-acting glargine instead of rapid-acting lispro (or vice versa). Both are clear solutions. Read label carefully. Double-check.
- Insulin — "U" abbreviation: Writing "10U" misread as "100" — tenfold overdose. Always write "10 units."
- Heparin concentration error: Multiple concentrations available (1,000 units/mL, 5,000 units/mL, 10,000 units/mL) — verify concentration against the order
- Opioid overdose: Failing to reassess after dose; giving PCA loading dose without monitoring; not having naloxone available
- Vasopressor extravasation: Peripheral IV administration of vasopressors causes tissue necrosis — central access strongly preferred
- Concentrated KCl: IV bolus of undiluted potassium chloride causes immediate cardiac arrest. Must be diluted and administered via slow infusion with cardiac monitoring.
- Anticoagulant — missed lab check: Giving warfarin without checking INR; giving heparin without monitoring aPTT — can result in supratherapeutic anticoagulation and serious bleeding
NCLEX Quick Tips
- High-alert medications are not necessarily given frequently — they cause the most serious harm when given in error
- Independent double-check = two nurses independently verify — not one nurse checking another's work
- Insulin: wrong type → life-threatening. Regular IV only. Long-acting never mixed.
- Anticoagulant reversal: Heparin → protamine. Warfarin → vitamin K. Dabigatran → idarucizumab. Factor Xa inhibitors → andexanet alfa.
- Opioids: have naloxone immediately available when giving IV opioids. Assess respiratory rate and sedation before each dose.
- Concentrated KCl IV push = always wrong. Must be diluted and infused. NEVER given IV push.
- Vasopressors: use smart pump with drug library. Titrate slowly. Central line preferred to prevent extravasation.
Related Resources
High-Alert Medications ReferenceISMP high-alert categories with in-depth safety considerations for each
Open →Anticoagulants for Nurses GuideMonitoring, bleeding precautions, reversal agents, and NCLEX pearls
Open →Insulin Administration and Safety GuideSafe injection technique, hypoglycemia prevention, and medication safety practices
Open →Vasoactive Medications ReferenceVasopressors: receptor profiles, clinical uses, and monitoring
Open →Vasopressor Comparison ChartSix vasoactive agents compared by receptor, BP/HR effect, and clinical use
Open →Anticoagulant Comparison ChartRoute, monitoring, reversal agents, and major risks side by side
Open →Standards & sources
Fact-checked Jun 20, 2026This page is written to align with ISMP High-Alert Medication List. It is an educational summary, not a citation of any single document — always verify specific doses, values, and protocols against current guidelines and your facility policy. How we source content →